WASHINGTON (Reuters) - U.S. congressional Democrats on Wednesday sharply criticized the Food and Drug Administration’s performance and said officials had failed to ask for adequate funding for inspections and drug safety oversight.
WASHINGTON (Reuters) - U.S. congressional Democrats on Wednesday sharply criticized the Food and Drug Administration’s performance and said officials had failed to ask for adequate funding for inspections and drug safety oversight.
